Can-Fite BioPharma Ltd(NYSE MKT:CANF) 
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, COVID-19 and erectile dysfunction. The company's lead drug candidate CF101 (Piclidenoson), which is in Phase III clinical tri...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.39
H 1.52
L 1.38
C 1.43
V 78,584
10EMA 1.43
20EMA 1.43
60EMA 1.43
120EMA 1.43
250EMA 1.43